A Pilot Trial of Pressure Muscle Index-Targeted PSV Trial
Launched by CAPITAL MEDICAL UNIVERSITY · Jan 7, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different methods for setting pressure support on ventilators for patients with severe breathing problems in the intensive care unit (ICU). The goal is to see if using a new measure called the Pressure Muscle Index (PMI) to adjust ventilator support leads to better outcomes compared to the traditional method, which adjusts support based on tidal volume (VT) and respiratory rate (RR). This trial will help researchers understand how well each method works and if they should conduct a larger study in the future.
To participate in this trial, patients must be adults who have recently started using a ventilator and are expected to need it for at least 24-48 hours. They should have specific breathing difficulties, but they cannot have certain medical conditions or be younger than 18 years old. During the trial, patients will receive ventilator support based on either the PMI or the traditional VT/RR method for a few weeks, and doctors will monitor their progress. The research team will also talk to healthcare providers to gather insights on what helps or hinders the trial process.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. PSV initiated during the last 24 hours, whether transition from controlled modes or primary initiation;
- • 2. Mechanical ventilation expected to be required for at least 24-48 hours by responsible physicians;
- • 3. The partial pressure of oxygen in arterial blood (PaO2)/inspired oxygen fraction (FiO2) ≤ 300 mmHg (measuring at clinical FiO2 and positive end-expiratory pressure \[PEEP\]);
- • 4. No sedation or stable sedation with Richmond Agitation Sedation Scale (RASS) of -2 to +1 or Riker's Sedation-Agitation Scale (SAS) of 3 to 4.
- Exclusion Criteria:
- • 1. Age younger than 18 years old;
- • 2. Initiation of PSV before ICU admission;
- • 3. Duration of mechanical ventilation longer than 7 days before enrollment;
- • 4. History of neuromuscular diseases;
- • 5. Clinical suspicion of increased intracranial pressure;
- • 6. Presentation with pneumothorax and/or bronchopleural fistula;
- • 7. Extracorporeal support;
- • 8. Moribund conditions;
- • 9. Refusal by the ICU physicians or the patient.
About Capital Medical University
Capital Medical University is a leading institution in medical education and research, dedicated to advancing healthcare through innovative clinical trials. With a strong emphasis on scientific rigor and ethical standards, the university collaborates with a network of healthcare professionals and researchers to drive breakthroughs in medical science. Capital Medical University aims to enhance patient care and improve health outcomes by fostering a multidisciplinary approach to clinical research, ensuring that its trials are designed to address critical health challenges and contribute valuable insights to the medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beijing, Beijing, China
Patients applied
Trial Officials
Jian-Xin Zhou, MD
Principal Investigator
Beijing Shijitan Hospital, Capital Medical University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported